Loading…
Dividends declared (per SOCE filings): FY2022 24,397 · FY2023 17,641 · FY2024 8,335 — 3-yr total 50,372
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company is a pharmaceutical company engaged in purchasing, processing, warehousing and wholesale distribution of pharmaceutical products across multiple countries.
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| 68,584 | 62,972 | 75,406 | 101,032 | 69,787 | 47,254 | 41,874 | 24,687 | -13.6% | |
| 90 | 75 | 63 | 54 | 47 | 15,577 | 18,866 | 6 | -31.3% | |
| TOTAL ASSETS | 68,674 | 63,047 | 75,469 | 101,085 | 69,834 | 31,677 | 23,009 | 24,693 | -13.6% |
| 4,984 | 7,655 | 8,914 | 12,895 | 9,519 | 9,096 | 13,748 | 15,803 | +17.9% | |
| 1,807 | 1,768 | 1,894 | 2,164 | 2,014 | 0 | 0 | 0 | nmf | |
| TOTAL LIABILITIES | 6,791 | 9,422 | 10,808 | 15,059 | 11,533 | 9,096 | 13,748 | 15,803 | +12.8% |
| 61,883 | 53,625 | 64,661 | 86,026 | 58,301 | 22,581 | 9,261 | 8,890 | -24.2% | |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||||||
| Total Debt | 1,504 | 1,804 | 1,930 | 2,184 | 2,033 | 0 | 0 | 0 | +7.8% |
| Cash & Equivalents | 1,896 | 812 | 384 | 334 | 1,228 | 606 | 5 | 5 | nmf |
| Net Debt | 392 | 992 | 1,546 | 1,849 | 805 | 606 | 5 | 5 | -45.8% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →